Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DALBAVANCIN vs DANAZOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DALBAVANCIN vs DANAZOL: Safety Overview

Metric DALBAVANCIN DANAZOL
Total FAERS Reports 1,107 477
Deaths Reported 54 71
Death Rate 4.9% 14.9%
Hospitalizations 288 142
Average Patient Age 61.0 yrs 51.7 yrs
% Female Patients 46.7% 34.9%
FDA Approval Date May 23, 2014 Approved Prior to Jan 1, 1982
Manufacturer Fresenius Kabi USA, LLC Teva Pharmaceuticals USA, Inc.
Route INTRAVENOUS ORAL
Marketing Status Prescription Discontinued